APO Research
Talk to an analyst

APO RESEARCH · REPORT

Argatroban

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

Selected research

Market Analysis & Forecast

Global Argatroban Market Analysis and Forecast 2026-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchArgatroban Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Argatroban Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Argatroban Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Argatroban Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Argatroban Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

Global Argatroban key players include Mitsubishi Tanabe Pharma, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, SANDOZ, etc. Global top four manufacturers hold a share nearly 60%.

Japan is the largest market, with a share about 35%, followed by Europe, and USA, both have a share about 55 percent.

Read the full market overview

In terms of product, Argatroban Injection is the largest segment, with a share over 70%. And in terms of application, the largest application is Heparin-induced thrombocytopenia (HIT), followed by Percutaneous Coronary Intervention, Cerebral arterial thrombosis.

This report presents an overview of global market for Argatroban, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Argatroban, also provides the sales of main regions and countries. Of the upcoming market potential for Argatroban, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Argatroban sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Argatroban market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Argatroban sales, projected growth trends, production technology, application and end-user industry.

Argatroban Segment by Company

Pfizer, Inc

SANDOZ

GlaxoSmithKline Plc

fresenius-kabi

Eagle Pharmaceuticals, Inc

Mitsubishi Tanabe Pharma

Teva Pharmaceutical Industries Ltd

WEST-WARD,INC

Argatroban Segment by Type

Argatroban Powder

Argatroban Injection

Argatroban Segment by Application

Heparin-induced Thrombocytopenia (HIT)

Percutaneous Coronary Intervention

Cerebral Arterial Thrombosis

Argatroban Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Argatroban market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Argatroban and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Argatroban.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Argatroban in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Argatroban manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Argatroban sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Argatroban Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Argatroban Powder Major Manufacturers Table 3. Argatroban Injection Major Manufacturers Table 4. Global Argatroban Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Heparin-induced Thrombocytopenia (HIT) Major Manufacturers Table 6. Percutaneous Coronary Intervention Major Manufacturers Table 7. Cerebral Arterial Thrombosis Major Manufacturers Table 8. Argatroban Industry Trends Table 9. Argatroban Industry Drivers Table 10. Argatroban Industry Opportunities and Challenges Table 11. Argatroban Industry Restraints Table 12. Global Argatroban Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Argatroban Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Argatroban Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Argatroban Revenue Market Share by Region (2021-2026) Table 16. Global Argatroban Revenue Market Share by Region (2027-2032) Table 17. Global Argatroban Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (g) Table 18. Global Argatroban Sales by Region (2021-2026) & (g) Table 19. Global Argatroban Sales by Region (2027-2032) & (g) Table 20. Global Argatroban Sales Market Share by Region (2021-2026) Table 21. Global Argatroban Sales Market Share by Region (2027-2032) Table 22. Global Argatroban Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Argatroban Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Argatroban Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Argatroban Sales Market Share by Manufacturers (2021-2026) Table 26. Global Argatroban Sales Price (USD/g) of Manufacturers (2021-2026) Table 27. Global Argatroban Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Argatroban Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Argatroban Manufacturers, Product Type & Application Table 30. Global Argatroban Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Argatroban by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Argatroban Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Argatroban Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Argatroban Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Argatroban Revenue Market Share by Type (2021-2026) Table 37. Global Argatroban Revenue Market Share by Type (2027-2032) Table 38. Global Argatroban Sales by Type 2021 VS 2025 VS 2032 (g) Table 39. Global Argatroban Sales by Type (2021-2026) & (g) Table 40. Global Argatroban Sales by Type (2027-2032) & (g) Table 41. Global Argatroban Sales Market Share by Type (2021-2026) Table 42. Global Argatroban Sales Market Share by Type (2027-2032) Table 43. Global Argatroban Price by Type (2021-2026) & (USD/g) Table 44. Global Argatroban Price by Type (2027-2032) & (USD/g) Table 45. Global Argatroban Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Argatroban Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Argatroban Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Argatroban Revenue Market Share by Application (2021-2026) Table 49. Global Argatroban Revenue Market Share by Application (2027-2032) Table 50. Global Argatroban Sales by Application 2021 VS 2025 VS 2032 (g) Table 51. Global Argatroban Sales by Application (2021-2026) & (g) Table 52. Global Argatroban Sales by Application (2027-2032) & (g) Table 53. Global Argatroban Sales Market Share by Application (2021-2026) Table 54. Global Argatroban Sales Market Share by Application (2027-2032) Table 55. Global Argatroban Price by Application (2021-2026) & (USD/g) Table 56. Global Argatroban Price by Application (2027-2032) & (USD/g) Table 57. Pfizer, Inc Company Information Table 58. Pfizer, Inc Business Overview Table 59. Pfizer, Inc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 60. Pfizer, Inc Argatroban Product Portfolio Table 61. Pfizer, Inc Recent Development Table 62. SANDOZ Company Information Table 63. SANDOZ Business Overview Table 64. SANDOZ Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 65. SANDOZ Argatroban Product Portfolio Table 66. SANDOZ Recent Development Table 67. GlaxoSmithKline Plc Company Information Table 68. GlaxoSmithKline Plc Business Overview Table 69. GlaxoSmithKline Plc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 70. GlaxoSmithKline Plc Argatroban Product Portfolio Table 71. GlaxoSmithKline Plc Recent Development Table 72. fresenius-kabi Company Information Table 73. fresenius-kabi Business Overview Table 74. fresenius-kabi Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 75. fresenius-kabi Argatroban Product Portfolio Table 76. fresenius-kabi Recent Development Table 77. Eagle Pharmaceuticals, Inc Company Information Table 78. Eagle Pharmaceuticals, Inc Business Overview Table 79. Eagle Pharmaceuticals, Inc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 80. Eagle Pharmaceuticals, Inc Argatroban Product Portfolio Table 81. Eagle Pharmaceuticals, Inc Recent Development Table 82. Mitsubishi Tanabe Pharma Company Information Table 83. Mitsubishi Tanabe Pharma Business Overview Table 84. Mitsubishi Tanabe Pharma Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 85. Mitsubishi Tanabe Pharma Argatroban Product Portfolio Table 86. Mitsubishi Tanabe Pharma Recent Development Table 87. Teva Pharmaceutical Industries Ltd Company Information Table 88. Teva Pharmaceutical Industries Ltd Business Overview Table 89. Teva Pharmaceutical Industries Ltd Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 90. Teva Pharmaceutical Industries Ltd Argatroban Product Portfolio Table 91. Teva Pharmaceutical Industries Ltd Recent Development Table 92. WEST-WARD,INC Company Information Table 93. WEST-WARD,INC Business Overview Table 94. WEST-WARD,INC Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 95. WEST-WARD,INC Argatroban Product Portfolio Table 96. WEST-WARD,INC Recent Development Table 97. North America Argatroban Revenue by Type (2021-2026) & (US$ Million) Table 98. North America Argatroban Revenue by Type (2027-2032) & (US$ Million) Table 99. North America Argatroban Sales by Type (2021-2026) & (g) Table 100. North America Argatroban Sales by Type (2027-2032) & (g) Table 101. North America Argatroban Sales Price by Type (2021-2026) & (USD/g) Table 102. North America Argatroban Sales Price by Type (2027-2032) & (USD/g) Table 103. North America Argatroban Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Argatroban Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Argatroban Sales by Application (2021-2026) & (g) Table 106. North America Argatroban Sales by Application (2027-2032) & (g) Table 107. North America Argatroban Sales Price by Application (2021-2026) & (USD/g) Table 108. North America Argatroban Sales Price by Application (2027-2032) & (USD/g) Table 109. North America Argatroban Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Argatroban Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. North America Argatroban Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. North America Argatroban Sales by Country (2021 VS 2025 VS 2032) & (g) Table 113. North America Argatroban Sales by Country (2021-2026) & (g) Table 114. North America Argatroban Sales by Country (2027-2032) & (g) Table 115. North America Argatroban Sales Price by Country (2021-2026) & (USD/g) Table 116. North America Argatroban Sales Price by Country (2027-2032) & (USD/g) Table 117. United States Argatroban Revenue (2021-2032) & (US$ Million) Table 118. Canada Argatroban Revenue (2021-2032) & (US$ Million) Table 119. Mexico Argatroban Revenue (2021-2032) & (US$ Million) Table 120. Europe Argatroban Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Argatroban Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Argatroban Sales by Type (2021-2026) & (g) Table 123. Europe Argatroban Sales by Type (2027-2032) & (g) Table 124. Europe Argatroban Sales Price by Type (2021-2026) & (USD/g) Table 125. Europe Argatroban Sales Price by Type (2027-2032) & (USD/g) Table 126. Europe Argatroban Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Argatroban Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Argatroban Sales by Application (2021-2026) & (g) Table 129. Europe Argatroban Sales by Application (2027-2032) & (g) Table 130. Europe Argatroban Sales Price by Application (2021-2026) & (USD/g) Table 131. Europe Argatroban Sales Price by Application (2027-2032) & (USD/g) Table 132. Europe Argatroban Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Argatroban Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Europe Argatroban Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Europe Argatroban Sales by Country (2021 VS 2025 VS 2032) & (g) Table 136. Europe Argatroban Sales by Country (2021-2026) & (g) Table 137. Europe Argatroban Sales by Country (2027-2032) & (g) Table 138. Europe Argatroban Sales Price by Country (2021-2026) & (USD/g) Table 139. Europe Argatroban Sales Price by Country (2027-2032) & (USD/g) Table 140. Germany Argatroban Revenue (2021-2032) & (US$ Million) Table 141. France Argatroban Revenue (2021-2032) & (US$ Million) Table 142. U.K. Argatroban Revenue (2021-2032) & (US$ Million) Table 143. Italy Argatroban Revenue (2021-2032) & (US$ Million) Table 144. Russia Argatroban Revenue (2021-2032) & (US$ Million) Table 145. Spain Argatroban Revenue (2021-2032) & (US$ Million) Table 146. Netherlands Argatroban Revenue (2021-2032) & (US$ Million) Table 147. Switzerland Argatroban Revenue (2021-2032) & (US$ Million) Table 148. Sweden Argatroban Revenue (2021-2032) & (US$ Million) Table 149. Poland Argatroban Revenue (2021-2032) & (US$ Million) Table 150. China Argatroban Revenue by Type (2021-2026) & (US$ Million) Table 151. China Argatroban Revenue by Type (2027-2032) & (US$ Million) Table 152. China Argatroban Sales by Type (2021-2026) & (g) Table 153. China Argatroban Sales by Type (2027-2032) & (g) Table 154. China Argatroban Sales Price by Type (2021-2026) & (USD/g) Table 155. China Argatroban Sales Price by Type (2027-2032) & (USD/g) Table 156. China Argatroban Revenue by Application (2021-2026) & (US$ Million) Table 157. China Argatroban Revenue by Application (2027-2032) & (US$ Million) Table 158. China Argatroban Sales by Application (2021-2026) & (g) Table 159. China Argatroban Sales by Application (2027-2032) & (g) Table 160. China Argatroban Sales Price by Application (2021-2026) & (USD/g) Table 161. China Argatroban Sales Price by Application (2027-2032) & (USD/g) Table 162. Asia Argatroban Revenue by Type (2021-2026) & (US$ Million) Table 163. Asia Argatroban Revenue by Type (2027-2032) & (US$ Million) Table 164. Asia Argatroban Sales by Type (2021-2026) & (g) Table 165. Asia Argatroban Sales by Type (2027-2032) & (g) Table 166. Asia Argatroban Sales Price by Type (2021-2026) & (USD/g) Table 167. Asia Argatroban Sales Price by Type (2027-2032) & (USD/g) Table 168. Asia Argatroban Revenue by Application (2021-2026) & (US$ Million) Table 169. Asia Argatroban Revenue by Application (2027-2032) & (US$ Million) Table 170. Asia Argatroban Sales by Application (2021-2026) & (g) Table 171. Asia Argatroban Sales by Application (2027-2032) & (g) Table 172. Asia Argatroban Sales Price by Application (2021-2026) & (USD/g) Table 173. Asia Argatroban Sales Price by Application (2027-2032) & (USD/g) Table 174. Asia Argatroban Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Asia Argatroban Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. Asia Argatroban Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. Asia Argatroban Sales by Country (2021 VS 2025 VS 2032) & (g) Table 178. Asia Argatroban Sales by Country (2021-2026) & (g) Table 179. Asia Argatroban Sales by Country (2027-2032) & (g) Table 180. Asia Argatroban Sales Price by Country (2021-2026) & (USD/g) Table 181. Asia Argatroban Sales Price by Country (2027-2032) & (USD/g) Table 182. Japan Argatroban Revenue (2021-2032) & (US$ Million) Table 183. South Korea Argatroban Revenue (2021-2032) & (US$ Million) Table 184. India Argatroban Revenue (2021-2032) & (US$ Million) Table 185. Australia Argatroban Revenue (2021-2032) & (US$ Million) Table 186. Taiwan Argatroban Revenue (2021-2032) & (US$ Million) Table 187. Southeast Asia Argatroban Revenue (2021-2032) & (US$ Million) Table 188. SAMEA Argatroban Revenue by Type (2021-2026) & (US$ Million) Table 189. SAMEA Argatroban Revenue by Type (2027-2032) & (US$ Million) Table 190. SAMEA Argatroban Sales by Type (2021-2026) & (g) Table 191. SAMEA Argatroban Sales by Type (2027-2032) & (g) Table 192. SAMEA Argatroban Sales Price by Type (2021-2026) & (USD/g) Table 193. SAMEA Argatroban Sales Price by Type (2027-2032) & (USD/g) Table 194. SAMEA Argatroban Revenue by Application (2021-2026) & (US$ Million) Table 195. SAMEA Argatroban Revenue by Application (2027-2032) & (US$ Million) Table 196. SAMEA Argatroban Sales by Application (2021-2026) & (g) Table 197. SAMEA Argatroban Sales by Application (2027-2032) & (g) Table 198. SAMEA Argatroban Sales Price by Application (2021-2026) & (USD/g) Table 199. SAMEA Argatroban Sales Price by Application (2027-2032) & (USD/g) Table 200. SAMEA Argatroban Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. SAMEA Argatroban Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. SAMEA Argatroban Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. SAMEA Argatroban Sales by Country (2021 VS 2025 VS 2032) & (g) Table 204. SAMEA Argatroban Sales by Country (2021-2026) & (g) Table 205. SAMEA Argatroban Sales by Country (2027-2032) & (g) Table 206. SAMEA Argatroban Sales Price by Country (2021-2026) & (USD/g) Table 207. SAMEA Argatroban Sales Price by Country (2027-2032) & (USD/g) Table 208. Brazil Argatroban Revenue (2021-2032) & (US$ Million) Table 209. Argentina Argatroban Revenue (2021-2032) & (US$ Million) Table 210. Chile Argatroban Revenue (2021-2032) & (US$ Million) Table 211. Colombia Argatroban Revenue (2021-2032) & (US$ Million) Table 212. Peru Argatroban Revenue (2021-2032) & (US$ Million) Table 213. Saudi Arabia Argatroban Revenue (2021-2032) & (US$ Million) Table 214. Israel Argatroban Revenue (2021-2032) & (US$ Million) Table 215. UAE Argatroban Revenue (2021-2032) & (US$ Million) Table 216. Turkey Argatroban Revenue (2021-2032) & (US$ Million) Table 217. Iran Argatroban Revenue (2021-2032) & (US$ Million) Table 218. Egypt Argatroban Revenue (2021-2032) & (US$ Million) Table 219. Key Raw Materials Table 220. Raw Materials Key Suppliers Table 221. Argatroban Distributors List Table 222. Argatroban Customers List Table 223. Research Programs/Design for This Report Table 224. Authors List of This Report Table 225. Secondary Sources Table 226. Primary Sources List of Figures Figure 1. Argatroban Image Figure 2. Global Argatroban Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Argatroban Market Size Share 2021 VS 2025 VS 2032 Figure 4. Argatroban Powder Image Figure 5. Argatroban Injection Image Figure 6. Global Argatroban Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Argatroban Market Size Share 2021 VS 2025 VS 2032 Figure 8. Heparin-induced Thrombocytopenia (HIT) Image Figure 9. Percutaneous Coronary Intervention Image Figure 10. Cerebral Arterial Thrombosis Image Figure 11. Global Argatroban Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Argatroban Revenue (2021-2032) & (US$ Million) Figure 13. Global Argatroban Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Argatroban Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Argatroban Revenue Market Share by Region (2021-2032) Figure 16. Global Argatroban Sales (2021-2032) & (g) Figure 17. Global Argatroban Sales by Region: 2021 VS 2025 VS 2032 (g) Figure 18. Global Argatroban Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Argatroban Sales YoY (2021-2032) & (g) Figure 20. Europe Argatroban Sales YoY (2021-2032) & (g) Figure 21. China Argatroban Sales YoY (2021-2032) & (g) Figure 22. Asia (Excluding China) Argatroban Sales YoY (2021-2032) & (g) Figure 23. South America, Middle East and Africa Argatroban Sales YoY (2021-2032) & (g) Figure 24. Global Argatroban Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Argatroban Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Argatroban Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Argatroban Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Argatroban Revenue Market Share by Type (2021-2032) Figure 30. Global Argatroban Sales by Type (2021 VS 2025 VS 2032) & (g) Figure 31. Global Argatroban Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Argatroban Sales Market Share by Type (2021-2032) Figure 33. Global Argatroban Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Argatroban Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Argatroban Revenue Market Share by Application (2021-2032) Figure 36. Global Argatroban Sales by Application (2021 VS 2025 VS 2032) & (g) Figure 37. Global Argatroban Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Argatroban Sales Market Share by Application (2021-2032) Figure 39. North America Argatroban Revenue Share by Type (2021-2032) Figure 40. North America Argatroban Sales Share by Type (2021-2032) Figure 41. North America Argatroban Revenue Share by Application (2021-2032) Figure 42. North America Argatroban Sales Share by Application (2021-2032) Figure 43. North America Argatroban Revenue Share by Country (2021-2032) Figure 44. North America Argatroban Sales Share by Country (2021-2032) Figure 45. Europe Argatroban Revenue Share by Type (2021-2032) Figure 46. Europe Argatroban Sales Share by Type (2021-2032) Figure 47. Europe Argatroban Revenue Share by Application (2021-2032) Figure 48. Europe Argatroban Sales Share by Application (2021-2032) Figure 49. Europe Argatroban Revenue Share by Country (2021-2032) Figure 50. Europe Argatroban Sales Share by Country (2021-2032) Figure 51. China Argatroban Revenue Share by Type (2021-2032) Figure 52. China Argatroban Sales Share by Type (2021-2032) Figure 53. China Argatroban Revenue Share by Application (2021-2032) Figure 54. China Argatroban Sales Share by Application (2021-2032) Figure 55. Asia Argatroban Revenue Share by Type (2021-2032) Figure 56. Asia Argatroban Sales Share by Type (2021-2032) Figure 57. Asia Argatroban Revenue Share by Application (2021-2032) Figure 58. Asia Argatroban Sales Share by Application (2021-2032) Figure 59. Asia Argatroban Revenue Share by Country (2021-2032) Figure 60. Asia Argatroban Sales Share by Country (2021-2032) Figure 61. SAMEA Argatroban Revenue Share by Type (2021-2032) Figure 62. SAMEA Argatroban Sales Share by Type (2021-2032) Figure 63. SAMEA Argatroban Revenue Share by Application (2021-2032) Figure 64. SAMEA Argatroban Sales Share by Application (2021-2032) Figure 65. SAMEA Argatroban Revenue Share by Country (2021-2032) Figure 66. SAMEA Argatroban Sales Share by Country (2021-2032) Figure 67. Argatroban Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Argatroban Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Argatroban Powder
  • Argatroban Injection
Applications
  • Heparin-induced Thrombocytopenia (HIT)
  • Percutaneous Coronary Intervention
  • Cerebral Arterial Thrombosis
Companies covered
  • Pfizer, Inc
  • SANDOZ
  • GlaxoSmithKline Plc
  • fresenius-kabi
  • Eagle Pharmaceuticals, Inc
  • Mitsubishi Tanabe Pharma
  • Teva Pharmaceutical Industries Ltd
  • WEST-WARD,INC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Argatroban Market by Type
  3. 1.2.1 Global Argatroban Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Argatroban Powder
  5. 1.2.3 Argatroban Injection
  6. 1.3 Argatroban Market by Application
  7. 1.3.1 Global Argatroban Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Heparin-induced Thrombocytopenia (HIT)
  9. 1.3.3 Percutaneous Coronary Intervention
  10. 1.3.4 Cerebral Arterial Thrombosis
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Argatroban Market Dynamics
  1. 2.1 Argatroban Industry Trends
  2. 2.2 Argatroban Industry Drivers
  3. 2.3 Argatroban Industry Opportunities and Challenges
  4. 2.4 Argatroban Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Argatroban Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Argatroban Revenue by Region
  3. 3.2.1 Global Argatroban Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Argatroban Revenue by Region (2021-2026)
  5. 3.2.3 Global Argatroban Revenue by Region (2027-2032)
  6. 3.2.4 Global Argatroban Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Argatroban Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Argatroban Sales by Region
  9. 3.4.1 Global Argatroban Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Argatroban Sales by Region (2021-2026)
  11. 3.4.3 Global Argatroban Sales by Region (2027-2032)
  12. 3.4.4 Global Argatroban Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Argatroban Revenue by Manufacturers
  2. 4.1.1 Global Argatroban Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Argatroban Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Argatroban Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Argatroban Sales by Manufacturers
  6. 4.2.1 Global Argatroban Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Argatroban Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Argatroban Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Argatroban Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Argatroban Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Argatroban Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Argatroban Manufacturers, Product Type & Application
  13. 4.7 Global Argatroban Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Argatroban Market CR5 and HHI
  16. 4.8.2 2025 Argatroban Tier 1, Tier 2, and Tier 3
5 Argatroban Market by Type
  1. 5.1 Global Argatroban Revenue by Type
  2. 5.1.1 Global Argatroban Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Argatroban Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Argatroban Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Argatroban Sales by Type
  6. 5.2.1 Global Argatroban Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Argatroban Sales by Type (2021-2032) & (g)
  8. 5.2.3 Global Argatroban Sales Market Share by Type (2021-2032)
  9. 5.3 Global Argatroban Price by Type
6 Argatroban Market by Application
  1. 6.1 Global Argatroban Revenue by Application
  2. 6.1.1 Global Argatroban Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Argatroban Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Argatroban Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Argatroban Sales by Application
  6. 6.2.1 Global Argatroban Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Argatroban Sales by Application (2021-2032) & (g)
  8. 6.2.3 Global Argatroban Sales Market Share by Application (2021-2032)
  9. 6.3 Global Argatroban Price by Application
7 Company Profiles
  1. 7.1 Pfizer, Inc
  2. 7.1.1 Pfizer, Inc Company Information
  3. 7.1.2 Pfizer, Inc Business Overview
  4. 7.1.3 Pfizer, Inc Argatroban Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer, Inc Argatroban Product Portfolio
  6. 7.1.5 Pfizer, Inc Recent Developments
  7. 7.2 SANDOZ
  8. 7.2.1 SANDOZ Company Information
  9. 7.2.2 SANDOZ Business Overview
  10. 7.2.3 SANDOZ Argatroban Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 SANDOZ Argatroban Product Portfolio
  12. 7.2.5 SANDOZ Recent Developments
  13. 7.3 GlaxoSmithKline Plc
  14. 7.3.1 GlaxoSmithKline Plc Company Information
  15. 7.3.2 GlaxoSmithKline Plc Business Overview
  16. 7.3.3 GlaxoSmithKline Plc Argatroban Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GlaxoSmithKline Plc Argatroban Product Portfolio
  18. 7.3.5 GlaxoSmithKline Plc Recent Developments
  19. 7.4 fresenius-kabi
  20. 7.4.1 fresenius-kabi Company Information
  21. 7.4.2 fresenius-kabi Business Overview
  22. 7.4.3 fresenius-kabi Argatroban Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 fresenius-kabi Argatroban Product Portfolio
  24. 7.4.5 fresenius-kabi Recent Developments
  25. 7.5 Eagle Pharmaceuticals, Inc
  26. 7.5.1 Eagle Pharmaceuticals, Inc Company Information
  27. 7.5.2 Eagle Pharmaceuticals, Inc Business Overview
  28. 7.5.3 Eagle Pharmaceuticals, Inc Argatroban Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Eagle Pharmaceuticals, Inc Argatroban Product Portfolio
  30. 7.5.5 Eagle Pharmaceuticals, Inc Recent Developments
  31. 7.6 Mitsubishi Tanabe Pharma
  32. 7.6.1 Mitsubishi Tanabe Pharma Company Information
  33. 7.6.2 Mitsubishi Tanabe Pharma Business Overview
  34. 7.6.3 Mitsubishi Tanabe Pharma Argatroban Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Mitsubishi Tanabe Pharma Argatroban Product Portfolio
  36. 7.6.5 Mitsubishi Tanabe Pharma Recent Developments
  37. 7.7 Teva Pharmaceutical Industries Ltd
  38. 7.7.1 Teva Pharmaceutical Industries Ltd Company Information
  39. 7.7.2 Teva Pharmaceutical Industries Ltd Business Overview
  40. 7.7.3 Teva Pharmaceutical Industries Ltd Argatroban Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Teva Pharmaceutical Industries Ltd Argatroban Product Portfolio
  42. 7.7.5 Teva Pharmaceutical Industries Ltd Recent Developments
  43. 7.8 WEST-WARD,INC
  44. 7.8.1 WEST-WARD,INC Company Information
  45. 7.8.2 WEST-WARD,INC Business Overview
  46. 7.8.3 WEST-WARD,INC Argatroban Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 WEST-WARD,INC Argatroban Product Portfolio
  48. 7.8.5 WEST-WARD,INC Recent Developments
8 North America
  1. 8.1 North America Argatroban Market Size by Type
  2. 8.1.1 North America Argatroban Revenue by Type (2021-2032)
  3. 8.1.2 North America Argatroban Sales by Type (2021-2032)
  4. 8.1.3 North America Argatroban Price by Type (2021-2032)
  5. 8.2 North America Argatroban Market Size by Application
  6. 8.2.1 North America Argatroban Revenue by Application (2021-2032)
  7. 8.2.2 North America Argatroban Sales by Application (2021-2032)
  8. 8.2.3 North America Argatroban Price by Application (2021-2032)
  9. 8.3 North America Argatroban Market Size by Country
  10. 8.3.1 North America Argatroban Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Argatroban Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Argatroban Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Argatroban Market Size by Type
  2. 9.1.1 Europe Argatroban Revenue by Type (2021-2032)
  3. 9.1.2 Europe Argatroban Sales by Type (2021-2032)
  4. 9.1.3 Europe Argatroban Price by Type (2021-2032)
  5. 9.2 Europe Argatroban Market Size by Application
  6. 9.2.1 Europe Argatroban Revenue by Application (2021-2032)
  7. 9.2.2 Europe Argatroban Sales by Application (2021-2032)
  8. 9.2.3 Europe Argatroban Price by Application (2021-2032)
  9. 9.3 Europe Argatroban Market Size by Country
  10. 9.3.1 Europe Argatroban Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Argatroban Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Argatroban Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Argatroban Market Size by Type
  2. 10.1.1 China Argatroban Revenue by Type (2021-2032)
  3. 10.1.2 China Argatroban Sales by Type (2021-2032)
  4. 10.1.3 China Argatroban Price by Type (2021-2032)
  5. 10.2 China Argatroban Market Size by Application
  6. 10.2.1 China Argatroban Revenue by Application (2021-2032)
  7. 10.2.2 China Argatroban Sales by Application (2021-2032)
  8. 10.2.3 China Argatroban Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Argatroban Market Size by Type
  2. 11.1.1 Asia Argatroban Revenue by Type (2021-2032)
  3. 11.1.2 Asia Argatroban Sales by Type (2021-2032)
  4. 11.1.3 Asia Argatroban Price by Type (2021-2032)
  5. 11.2 Asia Argatroban Market Size by Application
  6. 11.2.1 Asia Argatroban Revenue by Application (2021-2032)
  7. 11.2.2 Asia Argatroban Sales by Application (2021-2032)
  8. 11.2.3 Asia Argatroban Price by Application (2021-2032)
  9. 11.3 Asia Argatroban Market Size by Country
  10. 11.3.1 Asia Argatroban Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Argatroban Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Argatroban Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Argatroban Market Size by Type
  2. 12.1.1 SAMEA Argatroban Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Argatroban Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Argatroban Price by Type (2021-2032)
  5. 12.2 SAMEA Argatroban Market Size by Application
  6. 12.2.1 SAMEA Argatroban Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Argatroban Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Argatroban Price by Application (2021-2032)
  9. 12.3 SAMEA Argatroban Market Size by Country
  10. 12.3.1 SAMEA Argatroban Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Argatroban Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Argatroban Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Argatroban Value Chain Analysis
  2. 13.1.1 Argatroban Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Argatroban Production Mode & Process
  6. 13.2 Argatroban Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Argatroban Distributors
  9. 13.2.3 Argatroban Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst